
PRODUCT CLASSIFICATION
產(chǎn)品分類(lèi)產(chǎn)品展示/ Product display
您的位置:首頁(yè) / 產(chǎn)品展示 / / CAR T-Cell Therapy Cell Lines / 78772MART-1 TCR (DMF4) CD8+ NFAT-Luciferase Reporter Jurkat Cell Line

●Purchase●DescriptionThiscelllinewasgeneratedfromtheTCellReceptor(TCR)KnockoutNFATLuciferaseReporterJurkatCellLine(BPSBioscience#78556)byoverexpressionofhumanCD8(NM_001768
產(chǎn)品型號(hào):78772
廠商性質(zhì):生產(chǎn)廠家
更新時(shí)間:2023-11-11
訪(fǎng) 問(wèn) 量:228
立即咨詢(xún)
聯(lián)系電話(huà):
This cell line was generated from the T Cell Receptor (TCR) Knockout NFAT Luciferase Reporter Jurkat Cell Line (BPS Bioscience #78556) by overexpression of human CD8 (NM_001768.6) and MART-1-specific TCR (DMF4) using lentiviral transduction (CD8a Lentivirus #78648 and MART-1-Specific TCR Lentivirus Clone DMF4 #78678). The human TCR clone DMF4 specifically recognizes tumor antigen MART-1 (Melanoma-associated antigen recognized by T cells-1, or Melan-A).

Figure 1: Illustration of the functional co-culture assay used to validate the MART-1 TCR (DMF4) CD8+ NFAT-Luciferase Reporter Jurkat cell line.
Purchase of this cell line is for research purposes only; commercial use requires a separate license. View the full terms and conditions.
郵箱:infocn@bpsbioscience.com
傳真:
地址:上海靜安區(qū)